• Anna's DayBreak News
  • Posts
  • Prince Andrew Arrested, Private Credit Woes and Inhalable Tuberculosis Treatment

Prince Andrew Arrested, Private Credit Woes and Inhalable Tuberculosis Treatment

Anna's Daybreak News

Just facts, you think for yourself

Friday, 5:22 AM

February 20, 2026

Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

Former Prince Andrew Arrested

Former Prince Andrew was arrested in London on suspicion of misconduct in public office, the first senior British royal arrested in nearly 400 years.

The investigation centers on his extensive ties to Jeffrey Epstein, revealing contacts up to 2018 and allegations of sharing confidential government information. Police complaints include introducing women to Epstein and hosting some at Buckingham Palace.

Andrew settled a 2022 civil suit with Epstein accuser Virginia Giuffre, denying wrongdoing. King Charles III stripped Andrew of royal titles in 2025 but he remains in the succession line.

Police are also investigating former UK ambassador Peter Mandelson for sharing sensitive information with Epstein. The probe challenges the monarchy but underscores UK legal impartiality.

How confident are you that justice will be served in the case related to Epstein?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Look, if you’re trading off headlines, you’re already the yield.

Our latest intelligence brief just dropped, and it’s the ultimate cheat code for what the smart money is doing right now in the shadows.

While the crowd is distracted, Peter Fenton and Benchmark just anchored a massive $330M conviction play into a private AI juggernaut. Meanwhile, key insiders at NVIDIA and Walmart who have been relentlessly dumping stock all year? They just slammed the brakes. What do they see coming that you don't?

Oh, and Apple? They just quietly jacked their Washington lobbying spend by 192%—a $207M stealth operation into a brand new environmental playbook. They are front-running the regulators, and we caught it.

This brief isn't news. It's pure alpha. We’re connecting the dots between executive stock trades, Tier-1 VC mega-rounds, and D.C. shadow lobbying. It gives you the exact blueprint of where the highest-conviction capital is flowing—and exactly where the "dumb money" is about to get trapped.

You can either see the board before the pieces move, or you can keep wondering why you’re always one step behind. Read the brief. Get the edge.

Private Credit Woes

Blue Owl Capital halted investor redemptions at its retail-focused fund, liquidating $1.4 billion in loans near book value.

The fund plans to return 30% of capital within 45 days and switch from quarterly tender offers to distributions. Investor withdrawal requests surged 200% in Q4 2025, exceeding $2.9 billion across large BDCs.

Blue Owl shares fell nearly 6%, while Apollo and Blackstone shares dropped about 5%, amid concerns over liquidity risks in private credit. New investments slowed, with inflows to large funds declining 15% over three months.

Blue Owl’s loan sales included $600 million from its oldest BDC and $400 million from its tech-focused BDC, with 13% of loans to software firms.

Given Blue Owl’s suspension of fund redemptions, do you believe private credit funds are riskier than they are commonly perceived?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Ban on Big Investors Buying Single-Family Homes

The Trump administration proposes banning large investors owning over 100 single-family homes from buying more, exempting those who build or renovate for rentals.

The draft law targets hundreds of firms, below prior expectations of a 1,000-home threshold. The White House aims to add the ban to bipartisan housing bills now in Congress—the House bill passed without it, while the Senate considers inclusion.

The Treasury Secretary would gain authority to adjust investor definitions. Some Democrats oppose the plan due to exemptions and no mandate for existing owners to divest.

Experts doubt the ban will lower housing costs significantly, as institutional investors hold a small overall market share but dominate in cities like Atlanta and Phoenix.

Do you think institutional investors primarily harm or help rental markets?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Job Claims Drop

Initial US unemployment claims dropped by 23,000 to 206,000 for the week ending February 14, below the expected 225,000, marking the largest decline since November.

Continuing claims rose slightly to 1.87 million, the highest since early January 2026. The 4-week moving average of initial claims fell by 1,000 to 219,000, with the previous week's average revised up to 220,000.

The insured unemployment rate held steady at 1.2% for the week ending February 7. The data indicates labor market stability, with fewer new layoffs but some persistent unemployment from earlier weeks.

Does the recent drop in initial unemployment claims indicate that the US labor market is genuinely stabilizing?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Bubble Tea Risks

Bubble tea contains tapioca pearls made from cassava starch, which can absorb lead, leading to contamination.

Excessive pearl consumption may cause gastroparesis, intestinal blockages, and kidney stones due to oxalate and phosphate. Choking risks, especially for children, have caused fatalities.

Sugar content ranges from 20 to 50 grams per serving, exceeding that in soda, contributing to youth obesity, type 2 diabetes, cavities, and metabolic diseases. Studies link frequent consumption to higher anxiety and depression levels.

Tapioca pearls can mimic stones in medical imaging. Experts recommend consuming bubble tea occasionally and avoiding straws to reduce choking hazards.

Health risks include lead exposure, digestive issues, kidney stones, choking, high sugar intake, and possible mental health effects.

Sources: SciTechDaily

Have you ever consumed bubble tea?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Inhalable Tuberculosis Treatment

Researchers developed inhalable rifampin nanoparticles targeting lung macrophages to treat tuberculosis (TB).

This delivery keeps rifampin in the lungs up to seven days after one dose, contrasting with daily oral pills that cause liver damage and drug interactions. In mouse models, inhaled rifampin maintained higher lung levels and stimulated immune responses.

The method may reduce dosing frequency to weekly and limit side effects. It also has potential against non-tuberculous mycobacterial lung infections. Future research will explore combining inhaled rifampin with other TB drugs.

This approach could simplify TB treatment, enhance adherence, and reduce side effects associated with current therapies.

Sources: SciTechDaily

Are you comfortable with nanoparticle technology becoming common in drug delivery despite limited public understanding?

Click to see live results and comment!

Login or Subscribe to participate in polls.

When your own gut starts talking, especially if it’s got a solid history of telling the truth, you'd best pull up a chair and give it the floor.

Information is free. Intelligence is scarce.

You are one of 550,000 readers receiving this briefing. That is a crowd.

To join the 1,500 investors who receive our redacted contract briefings and wealth defense protocols, you need to step behind the velvet rope.

Join the Inner Circle.

Baked with love,

Anna Eisenberg ❤️

What did you think of today's edition?

Click to see live results and comment!

Login or Subscribe to participate in polls.